LGP4
Q4 2023 update: easy & affordable related M&A activity in the pharmaceutical industry
Analysis of the key themes driving M&A activity reveals that easy & affordable accounted for 3 pharmaceutical deals announced in…
Q4 2023 update: remote patient monitoring related M&A activity in the pharmaceutical industry
Analysis of the key themes driving M&A activity reveals that remote patient monitoring accounted for 3 pharmaceutical deals announced in…
Q4 2023 update: mobile health related M&A activity in the pharmaceutical industry
Analysis of the key themes driving M&A activity reveals that mobile health accounted for 4 pharmaceutical deals announced in Q4…
Q4 2023 update: cybersecurity related M&A activity in the pharmaceutical industry
Analysis of the key themes driving M&A activity reveals that cybersecurity accounted for 2 pharmaceutical deals announced in Q4 2023,…
Q4 2023 update: microbiome related M&A activity in the pharmaceutical industry
Analysis of the key themes driving M&A activity reveals that microbiome accounted for 3 pharmaceutical deals announced in Q4 2023,…